학술논문
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial.
Document Type
Journal Article
Author
Vranckx, Pascal; Valgimigli, Marco; Jüni, Peter; Hamm, Christian; Steg, Philippe Gabriel; Heg, Dik; van Es, Gerrit Anne; McFadden, Eugene P.; Yoshinobu Onuma; van Meijeren, Cokky; Chichareon, Ply; Benit, Edouard; Möllmann, Helge; Janssens, Luc; Ferrario, Maurizio; Moschovitis, Aris; Zurakowski, Aleksander; Dominici, Marcello; Van Geuns, Robert Jan; Huber, Kurt
Source
Subject
*ASPIRIN
*CLOPIDOGREL
*ADRENERGIC beta blockers
*PERCUTANEOUS coronary intervention
*SURGICAL stents
*DRUG dosage
*MYOCARDIAL infarction
*ADENOSINES
*CARDIOVASCULAR system
*COMBINATION drug therapy
*CLINICAL trials
*COMPARATIVE studies
*CORONARY disease
*RESEARCH methodology
*MEDICAL care
*MEDICAL cooperation
*NEUROTRANSMITTERS
*RESEARCH
*TICLOPIDINE
*EVALUATION research
*RANDOMIZED controlled trials
*PLATELET aggregation inhibitors
*DRUG-eluting stents
*CORONARY angiography
*PREVENTION
MYOCARDIAL infarction-related mortality
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
0140-6736
Abstract